Globavir Biosciences Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Globavir Biosciences Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10370
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Globavir Biosciences Inc (Globavir) is a biotechnology company that develop combination of drug therapies and diagnostic tests in the therapeutic areas of infection and immune-oncology. The company develops Globavir’s Drug Discovery Platform (GDDP), which generates small molecule candidates for the treatment of cancer and infectious diseases. The company’s lead product includes GBV006, a potent anti-infective for Ebola, development of dengue diagnostics and small molecule drugs to treat cancer and infection diseases. It also offers PanGlob, MulGlob and DenGlo for accurate diagnostics. The company has research collaborations with other pharmaceutical companies. Globavir is headquartered in Los Altos, California, the US.

Globavir Biosciences Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Globavir Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Globavir Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Globavir Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Globavir Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Globavir Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Globavir Biosciences Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Globavir Biosciences Raises USD0.1 Million in Venture Financing 10
Globavir Biosciences Secures USD4 Million in Venture Funding 11
Partnerships 12
Globavir Enters into Co-Development Agreement with Biomanguinhos 12
Bio-Rad Labs Enters into Licensing agreement with Globavir Biosciences 13
Globavir Enters into Licensing Agreement with Stanford University 14
Globavir Biosciences Inc – Key Competitors 15
Globavir Biosciences Inc – Key Employees 16
Globavir Biosciences Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Globavir Biosciences Inc, Medical Equipment, Key Facts 2
Globavir Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Globavir Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Globavir Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Globavir Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Globavir Biosciences Inc, Deals By Market, 2012 to YTD 2018 8
Globavir Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Globavir Biosciences Raises USD0.1 Million in Venture Financing 10
Globavir Biosciences Secures USD4 Million in Venture Funding 11
Globavir Enters into Co-Development Agreement with Biomanguinhos 12
Bio-Rad Labs Enters into Licensing agreement with Globavir Biosciences 13
Globavir Enters into Licensing Agreement with Stanford University 14
Globavir Biosciences Inc, Key Competitors 15
Globavir Biosciences Inc, Key Employees 16

List of Figures
Globavir Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Globavir Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Globavir Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Globavir Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Globavir Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Globavir Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Globavir Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Globavir Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Globavir Biosciences Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lincoln National Corporation:企業の戦略・SWOT・財務情報
    Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report Summary Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Dassault Aviation SA (AM):企業の財務・戦略的SWOT分析
    Dassault Aviation SA (AM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Denver Water:企業の戦略的SWOT分析
    Denver Water - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • ULURU Inc (ULUR):企業の財務・戦略的SWOT分析
    Summary ULURU Inc (ULURU) operates as a medical technology company that researches, develops, and markets wound care and muco-adhesive film products. The company’s products include Altrazeal and OraDisc. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of e …
  • Polyplex (Thailand) Public Company Limited:企業の戦略・SWOT・財務情報
    Polyplex (Thailand) Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Polyplex (Thailand) Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Kao Corporation:企業の戦略・SWOT・財務情報
    Kao Corporation - Strategy, SWOT and Corporate Finance Report Summary Kao Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • TMX Group Limited (X):企業の財務・戦略的SWOT分析
    TMX Group Limited (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ferro Corp (FOE):企業の財務・戦略的SWOT分析
    Ferro Corp (FOE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Arix Bioscience PLC (ARIX)-製薬・医療分野:企業M&A・提携分析
    Summary Arix Bioscience PLC (Arix Bioscience), formerly Arix Bioscience Ltd, is a healthcare and life science company. It offers financing and operational and strategic direction for the companies to support their businesses. The company’s expertise spans in various areas which include academic scie …
  • Daimler AG (DAI):企業の財務・戦略的SWOT分析
    Daimler AG (DAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • HUGO BOSS AG:企業の戦略・SWOT・財務情報
    HUGO BOSS AG - Strategy, SWOT and Corporate Finance Report Summary HUGO BOSS AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • aTyr Pharma Inc (LIFE):製薬・医療:M&Aディール及び事業提携情報
    Summary ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. The company’s ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to th …
  • China Yurun Food Group Limited:企業の戦略・SWOT・財務情報
    China Yurun Food Group Limited - Strategy, SWOT and Corporate Finance Report Summary China Yurun Food Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Manappuram Finance Limited (MANAPPURAM):企業の財務・戦略的SWOT分析
    Manappuram Finance Limited (MANAPPURAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Nuclear Power Corporation of India Ltd:企業の戦略的SWOT分析
    Nuclear Power Corporation of India Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • RTI Surgical Inc (RTIX):医療機器:M&Aディール及び事業提携情報
    Summary RTI Surgical Inc (RTI), formerly RTI Biologics Inc is a surgical implant company that offers biologic, metal and synthetic implants. The company’s products include spine implants, surgical specialties, sports medicine implants, cardiothoracic and orthobiologics. It offers spine implants such …
  • TVS Motor Co Ltd:戦略・SWOT・企業財務分析
    TVS Motor Co Ltd - Strategy, SWOT and Corporate Finance Report Summary TVS Motor Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Eneco Refresh Ltd:企業の戦略・SWOT・財務分析
    Eneco Refresh Ltd - Strategy, SWOT and Corporate Finance Report Summary Eneco Refresh Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sierra Nevada Corporation:企業の戦略・SWOT・財務情報
    Sierra Nevada Corporation - Strategy, SWOT and Corporate Finance Report Summary Sierra Nevada Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • The Ensign Group Inc (ENSG):製薬・医療:M&Aディール及び事業提携情報
    Summary The Ensign Group Inc (Ensign Group) is a healthcare service provider that offers patient care services. The organization offers post-acute care services including assisted living, skilled nursing, rehabilitative care, home health, home care, and hospice. It provides services such as medical, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆